Depression trials in Lithuania

3 of 3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  Where

  Kaunas, Lithuanian University of Health Sciences Kaunas Hospital, Psychiatric Clinic, Mariu division

  Age

  18 years to 65 years

  People

  470 worldwide

  Run by

  Intra-Cellular Therapies, Inc.

  See details and how to joinNCT05850689 · EU 2023-503836-41-00
• Phase 3Taking people
  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Kaunas, Klaipeda, Vilnius, Ziegzdriu K.

  Age

  18 years and over

  People

  850 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06966401 · EU 2024-519423-24-00
• Phase 3Taking people
  NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Kaunas, Klaipeda, Vilnius, Ziegzdriu K.

  Age

  18 years and over

  People

  200 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06911112 · EU 2024-519420-25-00